Single-use Bioreactors Market
Single-use Bioreactors Market - Global Industry Assessment & Forecast
Segments Covered
- By Product Single-use Bioreactor Systems, Single-use Media Bags, Single-use Filtration Assemblies, Other Products (Single-use vessels, tubing and connectors, samplers, and probes/sensor, and others)
- By Type Stirred-tank SUBs, Wave-induced SUBs, Bubble-column SUBs, Other SUBs (Hybrid bioreactors and SUBs with vertically perforated discs)
- By Type of Cell Mammalian Cells, Bacterial Cells, Yeast Cells, Other Cells (Insect and plant cells)
- By Molecule Type Monoclonal Antibodies, Vaccines, Gene-modified cells, Stem Cells, Other Molecules (Recombinant proteins including growth factors & interferons, antisense, RNA interference and others)
- By Application Research and Development (R&D), Process Development, Bioproduction
- By End User Pharmaceutical & Biopharmaceutical Companies, CROs & CMOs, Academic & Research Institutes
Snapshot
Base Year: | 2022 |
Forecast Years: | 2023 - 2030 |
Historical Years: | 2017 - 2021 |
Revenue 2022: | USD 4073.87 Million |
Revenue 2030: | USD 18230.00 Million |
Revenue CAGR (2023 - 2030): | 20.60% |
Fastest Growing Region (2023 - 2030) | Asia Pacific |
Largest Region (2022): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
Research Methodology: Single-use Bioreactors Market by Product by Type by Type of Cell by Molecule Type by Application by End User - Global Market Assessment, 2021 - 2028
Secondary Research
Primary Research:
The next stage involves the primary research conducted to gather further information and revalidate the data collected from the secondary research. Moreover, primary research is also conducted to identify key players in the market and to gather their market-specific financial information. A typical primary interview fulfills data requirements pertaining to first-hand information global market size, regional and segmental trends, competitive landscape expertise development and market understandings among others.
Data Triangulation and Market Size Estimations
Top-down and bottom-up approaches are used to validate and estimate the market size of the Single-use Bioreactors market. After the determination of the overall market size, the market is divided into various segments and sub-segments. Moreover, these same approaches mentioned above were used to derive and estimate market numbers for mentioned segments/sub-segments in the market. The data was triangulated by employing various data models and statistical techniques to arrive at exact statics and market size for each segment/sub-segment of the market.
FAQ
Frequently Asked Question
What is the global demand for Single-use Bioreactors in terms of revenue?
-
The global Single-use Bioreactors valued at USD 4073.87 Million in 2022 and is expected to reach USD 18230.00 Million in 2030 growing at a CAGR of 20.60%.
Which are the prominent players in the market?
-
The prominent players in the market are Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), Merck KGaA (Germany), Getinge AB (Sweden), Eppendorf AG (Germany), CESCO Bioengineering (US), Cellexus (US), PBS Biotech Inc. (US), Distek Inc. (US), ABEC (US), Able Corporation & Biott Corporation (Japan), G&G Technologies Inc. (US), Solida Biotech GmBH (Germany), Satake Chemical Equipment Mfg., Ltd. (Japan), Stobbe Pharma GmBH (Germany), Celltainer Biotech BV (Netherlands), Meissner Filtration Products Inc. (US), bbi-biotech GmBH (Germany), ENDEL ENGIE (France), OmniBRx biotechnologies (India), New Horizon Biotechnology Inc. (US), GPC Bio (US), Cell culture company (US), and Aptus bioreactors (US).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 20.60% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Single-use Bioreactors include
- the variation in sub-nuclear and cell assessments
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Single-use Bioreactors in 2022.